The Latest on Lung Ablation

Abstract

Lung cancer is the second most common cancer in both men and women. Despite smoking cessation efforts and advances in lung cancer detection and treatment, long-term survival remains low. For early-stage primary lung carcinoma, surgical resection offers the best chance of long-term survival; however, only about one-third of patients are surgical candidates. For nonsurgical candidates, minimally invasive percutaneous thermal ablation therapies have become recognized as safe and effective treatment alternatives, including radiofrequency ablation, microwave ablation, and cryoablation. Lung ablation is also an acceptable treatment for limited oligometastatic and oligorecurrent diseases. This article discusses the technologies and techniques available for tumor ablation of thoracic malignancies, as well as new treatments on the horizon.

Keywords

lung cancer - radiofrequency ablation - microwave ablation - cryoablation - interventional radiology

Publikationsverlauf

Artikel online veröffentlicht:
31. August 2022

• References

• 1 Cancer.org. 2021. Lung Cancer Guide | What You Need to Know. [online] Accessed September 11, 2021 at: https://www.cancer.org/cancer/lung-cancer.html
• 2 Robinson LA, Wagner Jr H, Ruckdeschel JC. American College of Chest Physicians. Treatment of stage IIIA non-small cell lung cancer. Chest 2003; 123 (1, Suppl): 202S-220S
• 3 Chheang S, Abtin F, Guteirrez A, Genshaft S, Suh R. Imaging features following thermal ablation of lung malignancies. Semin Intervent Radiol 2013; 30 (02) 157-168
• 4 de Baere T, Tselikas L, Catena V, Buy X, Deschamps F, Palussière J. Percutaneous thermal ablation of primary lung cancer. Diagn Interv Imaging 2016; 97 (10) 1019-1024
• 5 Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174 (01) 57-59
• 6 Jain SK, Dupuy DE, Cardarelli GA, Zheng Z, DiPetrillo TA. Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy. AJR Am J Roentgenol 2003; 181 (03) 711-715
• 7 Tafti BA, Genshaft S, Suh R, Abtin F. Lung ablation: indications and techniques. Semin Intervent Radiol 2019; 36 (03) 163-175
• 8 Palussière J, Catena V, Buy X. Percutaneous thermal ablation of lung tumors - radiofrequency, microwave and cryotherapy: Where are we going?. Diagn Interv Imaging 2017; 98 (09) 619-625
• 9 Pastorino U, Buyse M, Friedel G. et al; International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997; 113 (01) 37-49
• 10 Abtin F, De Baere T, Dupuy DE. et al. Updates on current role and practice of lung ablation. J Thorac Imaging 2019; 34 (04) 266-277
• 11 Mouli SK, Kurilova I, Sofocleous CT, Lewandowski RJ. The role of percutaneous image-guided thermal ablation for the treatment of pulmonary malignancies. AJR Am J Roentgenol 2017; 209 (04) 740-751
• 12 Lin M, Eiken P, Blackmon S. Image guided thermal ablation in lung cancer treatment. [published correction appears in J Thorac Dis. 2021 Jan;13(1):502] J Thorac Dis 2020; 12 (11) 7039-7047
• 13 Ma Y, Wallace AN, Waqar SN. et al. Percutaneous image-guided ablation in the treatment of osseous metastases from non-small cell lung cancer. Cardiovasc Intervent Radiol 2018; 41 (05) 726-733
• 14 Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques. Semin Intervent Radiol 2013; 30 (02) 141-150
• 15 Botsa EI, Thanou IL, Papatheodoropoulou AT, Thanos LI. Thermal ablation in the management of adrenal metastasis originating from non-small cell lung cancer: a 5-year single-center experience. Chin Med J (Engl) 2017; 130 (17) 2027-2032
• 16 Frenk NE, Daye D, Tuncali K. et al. Local control and survival after image-guided percutaneous ablation of adrenal metastases. J Vasc Interv Radiol 2018; 29 (02) 276-284
• 17 Sofocleous CT, Sideras P, Petre EN, Solomon SB. Ablation for the management of pulmonary malignancies. AJR Am J Roentgenol 2011; 197 (04) W581-W589
• 18 Mehta HJ, Ross C, Silvestri GA, Decker RH. Evaluation and treatment of high-risk patients with early-stage lung cancer. Clin Chest Med 2011; 32 (04) 783-797
• 19 Yang X, Ye X, Zhang L. et al. Microwave ablation for lung cancer patients with a single lung: clinical evaluation of 11 cases. Thorac Cancer 2018; 9 (05) 548-554
• 20 Ruscio L, Planche O, Zetlaoui P, Benhamou D. Percutaneous radiofrequency ablation of pulmonary metastasis and thoracic paravertebral block under computed tomographic scan guidance: a case report. A A Pract 2018; 11 (08) 213-215
• 21 Rose SC. Radiofrequency ablation of pulmonary malignancies. Semin Respir Crit Care Med 2008; 29 (04) 361-383
• 22 Cheung Ning M, Karmakar MK. Right thoracic paravertebral anaesthesia for percutaneous radiofrequency ablation of liver tumours. Br J Radiol 2011; 84 (1005): 785-789
• 23 García FJS, Aragón EM, Alvarez SA. et al. Ultrasound-guided thoracic paravertebral block for pulmonary radiofrequency ablation. J Cardiothorac Vasc Anesth 2022; 36 (02) 553-556
• 24 Steinke K, Haghighi KS, Wulf S, Morris DL. Effect of vessel diameter on the creation of ovine lung radiofrequency lesions in vivo: preliminary results. J Surg Res 2005; 124 (01) 85-91
• 25 Lubner MG, Brace CL, Hinshaw JL, Lee Jr FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010; 21 (08) , Suppl): S192-S203
• 26 Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37 (03) 171-186
• 27 Lyons GR, Askin G, Pua BB. Clinical outcomes after pulmonary cryoablation with the use of a triple freeze protocol. J Vasc Interv Radiol 2018; 29 (05) 714-721
• 28 Hiraki T, Tajiri N, Mimura H. et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 2006; 241 (01) 275-283
• 29 Lu Q, Cao W, Huang L. et al. CT-guided percutaneous microwave ablation of pulmonary malignancies: results in 69 cases. World J Surg Oncol 2012; 10: 80
• 30 Okuma T, Matsuoka T, Yamamoto A. et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol 2008; 31 (01) 122-130
• 31 Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T. Usefulness and limitation of manual aspiration immediately after pneumothorax complicating interventional radiological procedures with the transthoracic approach. Cardiovasc Intervent Radiol 2006; 29 (06) 1027-1033
• 32 Yoshimatsu R, Yamagami T, Terayama K, Matsumoto T, Miura H, Nishimura T. Delayed and recurrent pneumothorax after radiofrequency ablation of lung tumors. Chest 2009; 135 (04) 1002-1009
• 33 Cannella M, Cornelis F, Descat E. et al. Bronchopleural fistula after radiofrequency ablation of lung tumours. Cardiovasc Intervent Radiol 2011; 34 (Suppl. 02) S171-S174
• 34 Alberti N, Buy X, Frulio N. et al. Rare complications after lung percutaneous radiofrequency ablation: incidence, risk factors, prevention and management. Eur J Radiol 2016; 85 (06) 1181-1191
• 35 Nour-Eldin NE, Naguib NN, Mack M, Abskharon JE, Vogl TJ. Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern. Eur Radiol 2011; 21 (01) 197-204
• 36 Inoue M, Nakatsuka S, Yashiro H. et al. Percutaneous cryoablation of lung tumors: feasibility and safety. J Vasc Interv Radiol 2012; 23 (03) 295-302 , quiz 305
• 37 Sakurai J, Mimura H, Gobara H, Hiraki T, Kanazawa S. Pulmonary artery pseudoaneurysm related to radiofrequency ablation of lung tumor. Cardiovasc Intervent Radiol 2010; 33 (02) 413-416
• 38 Hiraki T, Gobara H, Mimura H. et al. Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases. J Vasc Interv Radiol 2010; 21 (07) 1129-1133
• 39 Matsui Y, Hiraki T, Gobara H. et al. Phrenic nerve injury after radiofrequency ablation of lung tumors: retrospective evaluation of the incidence and risk factors. J Vasc Interv Radiol 2012; 23 (06) 780-785
• 40 Palussière J, Canella M, Cornelis F. et al. Retrospective review of thoracic neural damage during lung ablation - what the interventional radiologist needs to know about neural thoracic anatomy. Cardiovasc Intervent Radiol 2013; 36 (06) 1602-1613
• 41 Yamakado K, Akeboshi M, Nakatsuka A. et al. Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol 2005; 28 (04) 530-532
• 42 Yamauchi Y, Izumi Y, Hashimoto K. et al. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer. PLoS One 2012; 7 (03) e33223
• 43 Livraghi T, Lazzaroni S, Meloni F, Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005; 92 (07) 856-858
• 44 Okuma T, Matsuoka T, Tutumi S, Nakmura K, Inoue Y. Air embolism during needle placement for CT-guided radiofrequency ablation of an unresectable metastatic lung lesion. J Vasc Interv Radiol 2007; 18 (12) 1592-1594
• 45 Maas M, Beets-Tan R, Gaubert JY. et al. Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice. Insights Imaging 2020; 11 (01) 83
• 46 Simon CJ, Dupuy DE, DiPetrillo TA. et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243 (01) 268-275
• 47 Kodama H, Yamakado K, Takaki H. et al. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention. Cardiovasc Intervent Radiol 2012; 35 (03) 563-569
• 48 McDevitt JL, Mouli SK, Nemcek AA, Lewandowski RJ, Salem R, Sato KT. Percutaneous cryoablation for the treatment of primary and metastatic lung tumors: identification of risk factors for recurrence and major complications. J Vasc Interv Radiol 2016; 27 (09) 1371-1379
• 49 Yamakado K, Inoue Y, Takao M. et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep 2009; 22 (04) 885-891
• 50 Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006; 13 (11) 1529-1537
• 51 de Baere T, Robinson JM, Rao P, Teriitehau C, Deschamps F. Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience. J Vasc Interv Radiol 2011; 22 (06) 749-754
• 52 Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 2008; 247 (03) 871-879
• 53 Yang X, Ye X, Zheng A. et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol 2014; 110 (06) 758-763
• 54 Healey TT, March BT, Baird G, Dupuy DE. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol 2017; 28 (02) 206-211
• 55 Moore W, Talati R, Bhattacharji P, Bilfinger T. Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol 2015; 26 (03) 312-319
• 56 Lencioni R, Crocetti L, Cioni R. et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9 (07) 621-628
• 57 Palussière J, Chomy F, Savina M. et al. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. J Cardiothorac Surg 2018; 13 (01) 91
• 58 de Baère T, Aupérin A, Deschamps F. et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 2015; 26 (05) 987-991
• 59 Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. [published correction appears in Radiology. 2013 Mar;266(3):1000] Radiology 2011; 261 (02) 643-651
• 60 de Baere T, Tselikas L, Woodrum D. et al. Evaluating cryoablation of metastatic lung tumors in patients–safety and efficacy: the ECLIPSE trial–interim analysis at 1 year. J Thorac Oncol 2015; 10 (10) 1468-1474
• 61 Callstrom MR, Woodrum DA, Nichols FC. et al. Multicenter study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE). J Thorac Oncol 2020; 15 (07) 1200-1209
• 62 Hiraki T, Gobara H, Iishi T. et al. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients. J Vasc Interv Radiol 2007; 18 (10) 1264-1269
• 63 Yamauchi Y, Izumi Y, Kawamura M. et al. Percutaneous cryoablation of pulmonary metastases from colorectal cancer. PLoS One 2011; 6 (11) e27086
• 64 Chua TC, Sarkar A, Saxena A, Glenn D, Zhao J, Morris DL. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol 2010; 21 (10) 2017-2022
• 65 Wu J, Bai HX, Chan L. et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: a national cancer database study. J Thorac Cardiovasc Surg 2020; 160 (05) 1350-1357.e11
• 66 Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010; 211 (01) 68-72
• 67 Kim SR, Han HJ, Park SJ. et al. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer. Eur J Radiol 2012; 81 (02) 395-399
• 68 Crabtree T, Puri V, Timmerman R. et al. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg 2013; 145 (03) 692-699
• 69 Song P, Sun W, Pang M, He W, Zhang W, Sheng L. Efficacy comparison between microwave ablation combined with radiation therapy and radiation therapy alone for locally advanced nonsmall-cell lung cancer. J Cancer Res Ther 2021; 17 (03) 715-719
• 70 Sebek J, Kramer S, Rocha R. et al. Bronchoscopically delivered microwave ablation in an in vivo porcine lung model. ERJ Open Res 2020; 6 (04) 00146-02020
• 71 Yoneda KY, Herth F, Spangler T, Raina S, Panescu D. Long-term survival results following endobronchial RF ablation in a healthy-porcine model. Annu Int Conf IEEE Eng Med Biol Soc 2020; 2020: 5252-5258
• 72 Chan JWY, Lau RWH, Ngai JCL. et al. Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance-a novel technique and initial experience with 30 cases. Transl Lung Cancer Res 2021; 10 (04) 1608-1622
• 73 Koizumi T, Tsushima K, Tanabe T. et al. Bronchoscopy-guided cooled radiofrequency ablation as a novel intervention therapy for peripheral lung cancer. Respiration 2015; 90 (01) 47-55
• 74 Zerbini A, Pilli M, Penna A. et al. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 2006; 66 (02) 1139-1146
• 75 Shao C, Yang M, Pan Y. et al. Case report: abscopal effect of microwave ablation in a patient with advanced squamous NSCLC and resistance to immunotherapy. Front Immunol 2021; 12: 696749